Tau exists as six closely related protein isoforms in the adult human brain. These are generated from alternative splicing of a single mRNA transcript and they differ in the absence or presence of two N-terminal and three or four microtubule binding domains. Typically all six isoforms have been considered functionally similar. However, their differential involvement in particular tauopathies raises the possibility that there may be isoform-specific differences in physiological function and pathological role. To explore this, we have compared the phenotypes induced by the 0N3R and 0N4R isoforms in Drosophila. Expression of the 3R isoform causes more profound axonal transport defects and locomotor impairments, culminating in a shorter lifespan than the 4R isoform. In contrast, the 4R isoform leads to greater neurodegeneration and impairments in learning and memory. Furthermore, the phosphorylation patterns of the two isoforms are distinct, as is their ability to induce oxidative stress. These differences are not consequent to different expression levels and are suggestive of bona fide physiological differences in isoform biology and pathological potential. They may therefore explain isoform-specific mechanisms of tau-toxicity and the differential susceptibility of brain regions to different tauopathies.
Introduction
Transcripts from the single microtubule associated protein tau (MAPT)-encoding gene on human chromosome 17q21.1 are spliced into six isoforms in the adult brain 1 . These tau isoforms, ranging in size from 352 to 441 amino acids, arise because of alternative splicing of exons 2, 3 and 10 leading to the absence or presence of 1 or 2 N-terminal domains and 3 or 4 C-terminal microtubule binding repeats 2 . They are commonly referred to as 0N3R, 1N3R, 2N3R, 0N4R, 1N4R and 2N4R tau. Furthermore, tau isoforms undergo a variety of posttranslational modifications including Ser/Thr and Tyr phosphorylation, acetylation and SUMOylation. Some of these modifications occur physiologically and are regulated during development and aging; others occur in pathological conditions and are implicated in taumediated toxicity (reviewed in 3, 4 ).
It has been argued that regulation of alternative splicing during development is a mechanism for radically altering the function of tau protein. This may be reflected in expression of 3R isoforms early in human brain development during axon path finding when a more dynamic cytoskeleton is required and then transitioning to expression of 4R isoforms post neurite elaboration, when a more stable network has been established 1 . Accordingly, a main distinction of tau isoforms involves differentiation of the microtubule-binding repeats. This likely underlies differences in isoform physiology and pathological potential as they ostensibly interact with distinct or partially overlapping membrane-associated, cytosolic and cytoskeletal proteins. In fact, differences in microtubule binding properties were well-known 5 ,
but several studies have now demonstrated additional isoform-specific differences including:
the propensity of tau to aggregate 6 , differential templated seeding capabilities 7 , intra-neuronal re-localisation during tangle formation 8, 9 , interactions with distinct cellular binding partners 10, 11 , phosphorylation potential and the impact of these differences on their biochemical properties 12 .
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The ratio of 3R to 4R isoforms in the adult human brain is approximately 1. The equimolar isoform ratio is disrupted in some familial tauopathies due to splicing mutations, which lead to elevation of the 4R tau isoforms 1 . Even in Alzheimer's Disease (AD) there is evidence of impaired 3R/4R ratio in tangle bearing neurons 13, 14 . The fact that disrupting the isoform ratio is associated with disease, demonstrates the importance of maintaining the 3R:4R isoform balance in healthy neurons. Additionally, not all isoforms are present in tau aggregates that characterise particular tauopathies, including sporadic forms. In AD for example, all tau isoforms form filaments, whereas in others they are comprised predominately of either 3R
(e.g. Pick's disease), or 4R isoforms (e.g. Progressive Supranuclear Palsy, Corticobasal
Degeneration, Argyrophilic Grain Disease) 15, 16 .
When divergent phenotypes are reported in animal models of tauopathy, the particular isoform expressed is not typically considered as a reason for the discrepancy. Here we highlight this by systematically assessing isoform-specific phenotypes in Drosophila and demonstrate that distinct tau isoforms can have significantly different effects in identical assays. This may shed light on the role of isoform-specific differences in the divergent pathogenic profiles of tauopathies where one of these isoforms predominates.
Materials and Methods

Flies
Female Drosophila melanogaster expressing either the motor neuron-specific driver D42-GAL4, pan-neuronal driver Elav C155 -GAL4 and Elav C155 -GAL4/TubGAL80 ts (Bloomington Stock Centre), sensory neuron driver panR7-GAL4 or retinal photoreceptor driver GMR-GAL4 were crossed with male flies transgenic for UAS-human 0N3R tau (UAS-hTau 0N3R ), or UAS-human 0N4R tau (two 4R transgenic lines were used and they are referred to as hTau 0N4R and hTau 0N4R*
; they are distinct transgene insertions presenting similar expression
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A C C E P T E D M A N U S C R I P T 5 levels -see Suppl. Figure 1) , or with wild-type Oregon-R male flies (WT). All transgenic lines and drivers were obtained from the Bloomington Stock centre (USA), except the UAShtau 0N4R and UAS-htau 0N4R* lines, which were originally generated by Prof. Mel Feany (Brigham and Women's Hospital, Boston, USA).
Larval locomotion analysis
As previously described 17 , wandering third instar larvae were allowed to crawl freely in a 10cm x 10cm plate, filled to a depth of approximately 4mm with dark blue agarose (1% agarose, 0.1% alcian blue), within a bioassay room kept at 21°C, 30-40% humidity, and controlled lighting conditions. After a 6-minute acclimatisation period, larvae were placed at the centre of the plate, and were filmed for 2 minutes using an Ikegami digital video camera and 5mm camera lens (Tracksys, UK). 4 such plates were filmed simultaneously. Ethovision movement analysis software (Noldus Information Technology) was then used to measure the following parameters of locomotion: velocity (mm/s); meander, measured as the angle deviated from the straight path per cm travelled (degrees/cm); and angular velocity (degrees/s). Further, the frequency of contractions of the body-wall muscles (contractions/min) was measured semi-manually from these video recordings, with the experimenter blinded to condition. GraphPad Prism was used to calculate standard error of the mean, unpaired 2-tailed students t-test, and/or 1-way ANOVA on the resulting data, as appropriate.
Adult climbing assay
This assay was performed on cohorts of 15 adult flies, which had been allowed to mate for 1-2 days after eclosion and then separated by sex and housed in their testing cohorts. Each week, 6-9 hours into the 12-hour light cycle of the flies, they were anaesthetised very briefly (<5 s)
with CO 2 and placed in a measuring cylinder in an assay room with controlled lighting conditions, temperature (23°C) and humidity (30-40%). They were given 15 min to recover
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A C C E P T E D M A N U S C R I P T 6 from anaesthesia and to acclimatise to the assay room. The measuring cylinder was tapped 3 times upon a mouse pad to send the flies to the bottom, a video recording was carried out and paused 10s later when the analysis was conducted. Flies rested for 2 min, and the procedure was repeated 2 more times. Flies were then placed onto fresh food until the following week.
Survival Assay
Three cohorts of 10 male flies of each genotype were separated 0-3 days post-eclosion and then transferred to new food twice a week and scored for deaths three times a week. Flies were housed in a room with controlled lighting conditions, temperature (23 °C) and humidity (30-40%) . A Kaplan-Meier survival curve was plotted and a Log-rank (Mantel-Cox) test was performed on the data using GraphPad Prism software.
Adult learning and memory assay
To obtain animals for learning and memory assays UAS-hTau 0N3R and UAS-hTau 
Tau solubility assay to enrich for oligomeric tau species
This assay enriches for insoluble oligomeric tau species as described 18 . A total of 10 fly heads were homogenised in 40 µl of TBS/sucrose buffer (50 mM Tris-HCl pH 7.4, 175 mM NaCl, 1 M sucrose, 5 mM EDTA and protease inhibitor cocktail). The samples were then spun for 2 min at 1000 g and the pellet discarded. The supernatant was spun at 186,000 g for 2 h at 4°C.
The resulting supernatant was "S1" -the aqueous soluble fraction. The pellet was resuspended at room temperature in 5% SDS/TBS buffer (50 mM Tris-HCl pH 7.4, 175 mM NaCl, 5% SDS) and spun at 186,000 g for 2 h at 25°C. The resulting supernatant was "S2" -the SDS-soluble, aqueous-insoluble fraction. The pellet was resuspended at room temperature in 5% SDS/TBS buffer (50 mM Tris-HCl pH 7.4, 175 mM NaCl, 5% SDS and protease inhibitor cocktail) and spun at 186,000 g for 2 h at 25°C as a wash spin; following which the supernatant was discarded. This pellet was then re-suspended in 8 M urea, 8% SDS buffer (50 mM Tris-HCl pH 7.4, 175 mM NaCl, 8% SDS, 8 M urea and protease inhibitor cocktail) and
agitated for 12-18 h at room temperature ("S3"). All samples were diluted in 2 x Laemmli buffer and boiled for 5 min. "S1" and "S2" were loaded equally (equivalent volumes) whereas double the amount of "S3" was loaded compared to "S1" and "S2". The S3 fraction was then quantified as a proportion of the sum total of all three fractions.
Protein oxidation assay (OxyBlot)
For each condition, 5 heads of 1 day-old flies were homogenized in 30 µl OxyBlot buffer (150 mM NaCl, 50 mM MES, 1% triton-X 100, 1% SDS, 2% β-mercaptoethanol, protease inhibitor cocktail). Homogenates were centrifuged for 5 min at 5,000 g, and the pellets discarded. 10µl homogenate was used for a carbonyl derivatisation reaction with the OxyBlot kit (Millipore), according to the manufacturer's instructions. Briefly, we added 10 µl 12% SDS, 20 µl DNPH (or negative control provided) and incubated 15 min at room temperature; then added 14 µl of neutralizing solution. 10 µl of this final labelled product was applied to nitrocellulose membrane (Amersham) using a slot blot apparatus (BioRad). Membranes were probed with anti-DNP antibody (Millipore, 1:150), and signal was detected using fluorescently conjugated anti-rabbit secondary antibody (LICOR) and a LiCor scanner with Odyssey software. Resulting band densities were measured using Image J software.
Western blotting
Western blotting was performed to assess total tau levels, phosphorylation and solubility state of tau. For western blot analysis of larval samples, 10 3 rd instar larvae or heads of 1-3d adult flies were pooled and homogenized in 200μl 1x Laemmli buffer, boiled at 95C for 5 min and centrifuged for 5 minutes at 14000 RPM, at RT. Proteins were separated by SDS-PAGE according to standard methods, and transferred to PVDF membrane by semi-dry transfer
Anti-Syntaxin (Developmental Hybridoma Bank) at 1:3000 was used as loading control.
Primary antibodies were used as follows: anti-human tau (Dako, 1:15,000 or T46, 1:3000).
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The phosphorylation-specific anti-tau antibodies Ser396/Ser404 (PHF-1) (a gift from Peter Davies, USA, 1:500), Ser396 (Source Biosciences, 1:2000), Ser202/Thr205 (AT8) (Thermo Scientific, 1:1000), Thr212/Ser214 (AT100) (Pierce Endogen, 1:1000), dephosphorylated at Ser199/Ser202/Thr205 (Tau-1) (Millipore, 1:2,000), pS262 (Invitrogen, 1:1,000). MC1 (a gift from Peter Davies, USA), was used at 1:200. Secondary antibodies were at 1:5000 and the signal detected by chemiluminescence (ECL plus).
Axonal transport studies
Wandering third instar (L3) larvae (day 5) were anaesthetised by placing larvae in a chamber 
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Images were assembled using Photoshop.
A C C E P T E D M A N U S C R I P T Results
Human 3-repeat tau and human 4-repeat tau expression present different phenotypes
To test whether the 0N3R and 0N4R isoforms yield identical, similar or distinct effects on larval mobility 17 , the UAS-hTau 0N3R and UAS hTau 0N4R transgenes were expressed in motor neurons under D42-GAL4. Using a semi-automated method to track larval locomotion 17 , we confirmed our previous observations that expression of hTau 0N3R in larval motor neurons manifests in locomotor defects. Significant impairments were evident in two larval locomotor parameters: meander and contractions ( Fig 1A-C) , which arise from impaired axonal transport ( Fig 1D) . In contrast, expression of hTau 0N4R did not result in significant locomotor deficits, or cause axonal transport impairments as profound as those induced by hTau 0N3R (Fig 1A-D) .
Isoform-specific phenotypes were also revealed in adult animals upon transgene expression with Elav-GAL4. Premature lethality was apparent in hTau 0N3R -expressing adult flies earlier than hTau 0N4R -expressing animals (Fig 2A) . In addition, isoform-specific differential effects were revealed on a negative geotaxis locomotor assay 19 in adult flies expressing paneuronally the two tau isoforms. The climbing ability of flies expressing hTau 0N3R starts to decline at 1 week and diminishes rapidly as animals progress to week 5 and 6, when the majority of the flies are virtually immobile (Fig. 2B ). By comparison, the climbing ability of flies expressing hTau 0N4R begins to deteriorate significantly one week later (week 2) and even at week 5, many of the flies remain mobile (Fig. 2B) . Similar results were observed with an independent UAS-0N4R transgene insertion (Suppl. Fig. 2 ), supporting the idea that this difference between the tau isoforms is of biological significance and not because of differential expression levels due to transgene insertion. Therefore, expression of 0N3R tau appears to precipitate more severe effects than 0N4R expression in the same neurons.
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Collectively the results indicate differential effects of the two tau isoforms on survival and larval and adult locomotion. Therefore, we wondered whether such differential isoformspecific effects may be revealed in additional neuronal subpopulations.
We selected a subset of eye sensory neurons to assay the effects of these isoforms since the fly retina has been used extensively to study tau-dependent neurodegeneration. Each tau isoform was co-expressed with membrane-tagged RFP (myristolated-RFP) in R7 sensory receptor neurons (pan-R7-GAL4). Degeneration was not apparent at 5 days post-eclosion evidenced by anti-RFP staining of axons following expression of either isoform ( Fig. 3A-C) .
By day 20 however, degeneration was apparent in the sensory neurones expressing either of the isoforms, but with those expressing hTau 0N4R (Fig. 3E , H) presenting more extensive aberrations than those expressing hTau 0N3R (Fig. 3D, G) . By 40 days post-eclosion, the sensory neurones expressing htau 0N4R had largely degenerated with only few axons remaining (Fig. 3J, M) . In contrast, more axons remained in animals expressing hTau 0N3R at this time time-point (Fig. 3I, L ). This data indicates that when expressed in the adult visual sensory neurones, hTau 0N4R exhibits a stronger neurodegenerative phenotype than hTau 0N3R .
Interestingly, in 40 day-old hTau 0N4R brains myr-RFP expression is nearly absent (Fig. 3J ), but accumulation of tau along the axons persists (Fig. 3M ), indicating loss of membrane integrity leaving 'ghost' axonal scaffolds behind. We confirmed the loss of membrane integrity by expressing the tau isoforms in all photoreceptors (under GMR-GAL4) and using antibodies against the membrane glycoprotein Chaoptin 20 . In 40 day-old hTau 0N4R expressing optic lobes, Chaoptin is completely absent, whereas although severely reduced in hTau 0N3R expressing neurons, it is still detectable (Suppl. Fig. 3 ). Therefore, the results from both myr-RFP and Chaoptin membrane markers confirm that although tau expression disrupts membrane integrity, the severity is isoform-specific with hTau 0N4R precipitating a stronger neurodegenerative phenotype than hTau 0N3R .
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To further explore whether such isoform-dependent differences persisted in other adult assays, we undertook conditional pan neuronal expression of both isoforms in the adult CNS because hTau 0N4R expression has been reported to yield learning deficits in this assay 21 . Hence we investigated whether adult specific expression of 0N3R might also precipitate such deficits in learning and 24 hr memory (long term memory-LTM). Surprisingly, while 0N4R expression impaired associative learning (Fig 4A) in agreement with prior results 21, 22 and LTM was similarly significantly impaired (Fig 4B) , expression of hTau 0N3R did not affect either of these processes (Fig 4C, D) .
Collectively then, our data demonstrate that distinct larval and adult neuronal populations are differentially sensitive to the neuro-toxic effects of 0N3R and 0N4R tau isoforms, precipitating phenotypic strength differences, or lack of discernable phenotypes.
This in turn strongly suggests that the effects of tau expression in Drosophila are not merely a consequence of non-specific toxicity or dysfunction due to overexpression of an exogenous protein.
Rather it is likely that human tau isoforms interact differentially with the same or different intra-neuronal clients as suggested by the specificity and range of phenotypes described above.
Isoforms engage different mechanisms of toxicity Differences in phenotypic strength can be precipitated by expression level differences.
However this is unlikely to be key for the differences we report since the expression of the two tau isoforms is comparable in the transgenic lines we have employed (Suppl. Fig. 1 ). To investigate whether the two tau isoforms act differently at the cellular/molecular level, we assessed their accumulation, solubility, phosphorylation status and oxidative stress potential because these are other properties implicated in mechanisms of tau toxicity 23 .
We have previously reported that increased tau levels lead to aggregation 18 and accordingly we have found elevated accumulation of tau with increasing age in both 0N3R
and 0N4R adults (data not shown). We therefore explored whether the age-dependent accumulation of tau led to its aggregation. Using a commonly used biochemical insolubility assay that enriches for insoluble oligomeric tau species 18 , we found little evidence of significant levels of insoluble tau oligomers in the brains of adult flies expressing 0N3R or 0N4R pan-neuronally, even in older flies (Fig. 5A) . Though insoluble oligomeric tau species
were not abundant, substantial isoform-specific aggregate profiles were not revealed upon fractionation of brain extracts expressing 0N3R or 0N4R (Fig. 5B) . We did not investigate whether larger insoluble tau aggregates, such as tau filaments are found in these transgenics, because they have been described in some 24 , but not all Drosophila tauopathy models 25 .
Of the six isoforms, 0N3R is most highly phosphorylated 26 , but whether the other tau isoforms undergo differential post-translational modifications has been unclear. Therefore we sought to determine whether the two isoforms were phosphorylated differentially in larval motor neurons implicated in the isoform-specific locomotor behaviours and in adult brains to potentially mirror the isoform-specific learning, memory and longevity differences. Hence, we expressed 0N3R or 0N4R specifically in larval motor neurons or adult brains and then probed the occupation status of a set of phosphorylation sites implicated in tauopathies.
Though phosphorylation at many sites was similar in larval motor neurons, there were some interesting isoform-specific differences. Phosphorylation at Ser 262 (Fig. 6A) , Thr 231 (AT180 - Fig. 6D ), and Ser 396 (Fig. 6E) did not appear significantly different between isoforms in larvae. However, the signal with the AT100 antibody appeared elevated in hTau 0N3R -expressing larvae (Fig 6F) . Phosphorylation at the AT8 site was also elevated in hTau 0N3R -expressing larvae, while in hTau 0N4R -expressing animals AT8 phosphorylation was
suppressed as revealed by the Tau-1 antibody which is reactive to non-phosphorylated epitopes at the AT8 site ( Fig. 6 B and C) .
As with the larval motor neurons, the 0N3R and 0N4R isoforms were similarly phosphorylated at most epitopes in adult brain, but there were some interesting differences suggesting that developmental stage influences tau phosphorylation in an isoform-specific manner. These differences were genuine because they were evident even when the independent 0N4R p-element insertion line hTau 0N4R* was used (Fig. 7) . In larval motor neurons, 0N3R tau is more phosphorylated than 0N4R tau at the AT8 site (as evidenced by increased AT8 and decreased Tau-1 immunoreactivity in 0N3R motor neurons) whereas in adult brain, 0N4R tau is more phosphorylated than 0N3R tau at these sites (as indicated by greater Tau-1 immunoreactivity in 0N3R brains) ( Fig. 6 and 7) . Similarly the greater phosphorylation of 0N3R tau at the AT100 site in larval motor neurons is not evident in adult brain (Fig 6 and 7) . Instead, 0N3R tau is more phosphorylated at the Ser 396/404 (detected by PHF-1 with an increased trend seen with an antibody that only picks up phosphorylation at Ser 396) than 0N4R tau in adult brains but not in larval motor neurons (Fig 6 and 7) .
Significantly, the 0N3R isoform is much more immunoreactive with the MC1 antibody than the 0N4R proteins, suggesting differences in folding or pathology-related structure between the two isoforms.
In summary the data implies that 0N3R and 0N4R isoforms are differentially phosphorylated at some but not all sites in different developmental stages. Whether these sitespecific phosphorylation differences underpin the differential phenotypes precipitated by the two isoforms is yet to be determined, but is consistent with the data. Moreover, because the phosphorylation profiles of these tau isoforms on tauopathy associated sites are not identical, the data support the notion of isoform-specific interactions with kinases and phosphatases.
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Aside from phosphorylation and aggregation, oxidative stress is another mechanism by which tau mediates toxicity 27, 23 . We therefore examined oxidative stress using a commercial assay to detect oxidised proteins in brain homogenates from flies expressing either tau isoform pan-neuronally. Though there was clear evidence of oxidative stress in brains from both transgenic lines, surprisingly, oxidation detected in hTau 0N4R -expressing flies was twice as much as of that detected in hTau 0N3R -expressing animals (Fig. 8) . This again demonstrates a clear isoform-specific difference, which may underpin some of the isoform-specific differences in toxicity and neuronal dysfunction described here by us and by others in various tauopathy models.
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We report here isoform-specific phenotypes in both larval and adult Drosophila expressing either hTau 0N3R or hTau 0N4R transgenes. Although expression level differences may contribute to the phenotypic consequences, isoform-specific differences independent of this were uncovered in this study. These results are in agreement with independent studies, which have also demonstrated isoform-specific differences in physiological tau biology, including sub-cellular localisation and function, and disease-relevant biochemical properties 9, 11 .
Differences in the best-described cellular function of tau, microtubule binding, have long been known, and believed to arise because the 4R isoforms possess an extra microtubule-binding domain enabling three-fold greater microtubule affinity 5 . However, the flanking carboxy-terminal region also differentially regulates microtubule-binding, and curiously appears to influence binding of 3R isoforms to a greater extent than 4R isoforms 5 .
In addition to microtubule-binding, isoform specific differences have been identified in several other physiological roles attributed to tau. This includes interacting partners, with 2N4R isoforms exhibiting stronger affinity to proteins implicated in neurodegeneration 11 and interactions with kinases such as Fyn, which binds preferentially to 3R tau 10 . Differences in sub-cellular localisation have also been uncovered, wherein 0N isoforms appear preferentially in the soma and axons, 1N isoforms in the dendrites and nucleus and 2N isoforms in cell bodies and axons 9 . Such results challenge the widely-held view that tau behaves preferentially as an axonal protein engaged mostly in microtubule stabilisation, and jointly with the data herein, promote the idea that tau is a protein of multiple functions which are likely sub-served differentially by distinct isoforms.
Further support for this notion is provided by isoform-specific differences in pathological behaviour including propensity to aggregate 6 , morphology of aggregates formed 6 and templated seeding 7 . Templated seeding of filaments in particular, exhibits striking isoform-specific barriers. Whilst seeds containing 3R isoforms alone or 3R and 4R isoforms ACCEPTED MANUSCRIPT
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18 together can recruit both 3R and 4R monomers into growing filaments, seeds comprising just of 4R isoforms can only recruit 4R monomers 7 . Since hyper-phosphorylation of tau is believed to promote its aggregation, some studies have explored the impact of pseudophosphorylation on aggregation in vitro and identified interesting isoform-specific differences 12 . Although we have revealed isoform-specific, developmental stage-dependent phosphorylation differences, these do not appear to lead to aggregation differences, at least within the resolution afforded by our techniques, but clearly appear consistent with the distinct phenotypic consequences we detailed. Differences have also been reported in the subcellular localisation of the different tau isoforms and how this changes during the evolution of tangle pathology 8 . Collectively these studies begin to elucidate why different tau isoforms are preferentially affected in different tauopathies and the cellular/molecular basis for predilection of different brain regions therein.
The studies discussed above show clear isoform-specific differences in the biochemical and pathological properties of tau; however not many studies have directly compared and contrasted isoform-specific phenotypic differences in the same model. Adding to this, we show here that for some tau-mediated phenotypes, like axonal transport disruption and adult locomotion, the 3R tau isoform is more detrimental whereas in other tau-mediated phenotypes, such as learning and memory and photo-receptor degeneration, it is the 4R tau which is more toxic. In line with this, we have previously shown that expression of either hTau 0N4R or hTau 2N4R but not hTau 0N3R eliminates Drosophila mushroom bodies 21, 28, 29 , and that expression of hTau 0N3R is associated with dysfunction in the absence of neuronal death 19, 30 . Likewise, many other Drosophila models of tauopathy report degeneration, mainly of photoreceptors or other brain regions, but most studies invariably express 4R isoforms 31, 32 .
Moreover, to our knowledge, no other studies have directly compared the oxidative potential of 3R and 4R isoforms. We provide evidence that the 0N4R isoform is more potent at
19 inducing oxidative stress than 0N3R. Oxidative stress has been reported in tauopathies implicating either or both 3R and 4R isoforms (reviewed in 23 ). Whether, as our data suggests, it plays a more profound role in diseases involving 4R remains to be determined. In fact, of the few studies that have systematically compared 3R and 4R mediated phenotypes in the same model, work in mice suggests that tipping the balance towards 4R isoforms was associated with greater pathology and behavioural defects 33 .
The molecular mechanism(s) underpinning the divergent phenotypes of tau isoforms are unclear at present. Expression level and stability differences are likely contributing factors because tau-toxicity is generally believed to correlate with intraneuronal tau load 34 . This notion is significantly supplemented and enhanced by our own results uncovering phenotypic differences between hTau 0N3R and hTau 0N4R , which persisted even in the face of comparable expression levels. Differences in the epitopes phosphorylated may be another contributing factor since such differences have been associated with differential toxicity 35 , or reduced microtubule binding 36 which underpins tau-mediated neuronal dysfunction 30, 37 .
Conclusion:
The six tau isoforms are often regarded as the same protein. Indeed many of their normal biological and pathological characteristics are very similar. However, there are distinct differences in isoform functional properties arising from the variable N-terminal domains and 3 or 4 microtubule-binding domains. This manifests in variations in their post-translational regulation and in turn their normal cellular functions. Adding to this, we report here that they are distinctly different in their pathological potential as well. Such isoform-specific differences need to be taken into account when interpreting data from experimental models of tauopathy since they will invariably differ from model to model. It should also inform taucentric therapeutic approaches. It remains to be investigated how the tau isoforms contribute
to differential susceptibility of brain region and mechanism of tau-toxicity in different tauopathies. Tau expression was driven using the D42-GAL4 motor neuron specific driver. Tau phosphorylation was assessed in wandering third instar larvae. Representative blots are shown for at least two independent experiments. Both isoforms of tau were phosphorylated to similar extents at the pS262 site (A), AT180 site (D) and pS396 site (E). However hTau 0N4R* was less phosphorylated at the AT8/Tau-1 site (B and C) and AT100 site (F). Expression of both isoforms of tau is comparable (G). hTau 0N3R = {w/+ ; D42-GAL4/+; UAShTau 0N3R /+}. 
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Highlight
Tau exists as six closely related protein isoforms in the adult human brain. These are generated from alternative splicing of a single mRNA transcript and they differ in the absence or presence of two N-terminal and three or four microtubule binding domains. Typically all six isoforms have been considered functionally similar. However, their differential involvement in particular tauopathies raises the possibility that there may be isoform-specific differences in physiological function and pathological role. To explore this, we have compared the phenotypes induced by the 0N3R and 0N4R isoforms in Drosophila. Expression of the 3R isoform causes more profound axonal transport defects and locomotor impairments, culminating in a shorter lifespan than the 4R isoform. In contrast, the 4R isoform leads to greater neurodegeneration and impairments in learning and memory. Furthermore, the phosphorylation patterns of the two isoforms are distinct, as is their ability to induce oxidative stress. These differences are not consequent to different expression levels and are suggestive of bona fide physiological differences in isoform biology and pathological potential. They may therefore explain isoform-specific mechanisms of tau-toxicity and the differential susceptibility of brain regions to different tauopathies.
